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Perceptual Mapping - 1
– Perceptual mapping: Graphical display summarizing
consumers’ perceptions of multi-attribute objects.
– Example: Displaying brands in a product class together 
with their attributes
e.g. brands for treating stomach problems.
– Brunswik’s (1955) Lens Model:
Theoretical foundation for understanding the importance of 
perceptions in consumer purchases 
Perceptions Preferences Choice
Perceptual Mapping - 2
• Goals perceptual mapping
– Aid for strategic marketing decisions 
– Summarizing nature and degree of competition among a set 
brands via key product attributes.
• Common application areas
– product positioning
– identification of market gaps for new product development. 
• Basic data 
– Brands are scored on a number of attributes by
several individuals
– Scores averaged over individuals
– Result: Brand by Attribute matrix
• Common data analysis techniques  
– correspondence analysis
– principal component analysis, 
– multidimensional analysis 
– discriminant analysis
– factor analysis
Perceptual Mapping - 3
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Perceptual Mapping - 4
• Basic data
– Doctor thinks a brand posesses an attribute => 
score = 1 , if not: score = 0
– Three-way binary data: Brands × Attributes × Doctors
– Why average over doctors?
– Different doctors may be sensitive to different 
attributes
• Three-way data analysis techniques  
– Three-mode binary hierarchical cluster analysis
– Three-mode principal component analysis (numerical)
The Binary Data Cube
i=1,....,I
Objects (Brands)
MODE  A k=1,...,K
Subjects (Doctors)
MODE  C
Fibers Slices
MODE  B
j=1,...,J
Variables (Attributes)
011001
100101
111000
Stacked Two-Way Data
Columns: Attributes
1 through J
Doctor 1 (k=1)
Doctor 2 (k=2)
Doctor K (k=K)
Rows: Brands 1 through I
Rows: Brands 1 through I
Rows: Brands 1 through I
011001
100101
111000
010001
101101
111010
010001
010101
110001
HICLAS3: Algebraic Representation
(Tucker3-HICLAS)
• Hiclas3 model  (uses Boolean algebra)
• mijk =1 iff ãip= 1 and bjq= 1 and ckr = 1 and gpqr = 1 for at least 
one combination of p, q, and r;
• ãip, bjq, ckr : elements binary component matrices A, B, and C, 
respectively (brands, attributes, doctors).
• gpqr : element of the P×Q×R three-way binary core array G, 
indicates links between binary components of the three modes
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HICLAS3 – Pictorial Representation
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m211 = 1 as a22b12c11g221 = 1×1 × 1 × 1 (all other 7 combinations contain a zero)
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Three-Mode Component Analysis
• Tucker3 model (numerical)
– i=1,...,I (brands); j=1,...,J (attributes); k=1,...,K (doctors); 
– mijk is the model matrix or structural image
– aip, bjq, ckr : elements loading matrices A, B, and C, 
respectively (brands, attributes, doctors).
– gpqr : element of the P×Q×R three-way core array G; 
indicates strength of the link between the components of 
the three modes
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Three-Mode Binary Analysis in Action
Perceptions of Medical Doctors
w.r.t.
Gastro-Intestinal Drugs
Perceptions of Medical Doctors
Gastro-Intestinal Drugs
• Tagamet 
• Zantac 
• Pepcid
• Axid 
• Sulcrate
• Cytotec
• Losec
Attributes
Adjectives [Binary answers– no (0) or yes (1)]
• Relieves Pain RelPain
• Does not have serious side effects NoSideEf
• Relatively safe w.r.t. 
potential interactions with other drugs Safe
• Flexible in terms of  dosage FlexDose
• Not too costly for the patient LowCost
• Relieves symptoms RelSymptoms
• Promotes healing Heals
• Prophylactic Prophylactic
Data: Brands × Attributes × Doctors
(7×8×283)
i=1,....,7
Objects (Brands)
MODE  A
j=1,...,8
Variables (Attributes)
MODE  B
k=1,...,283
Subjects (Doctors)
MODE  C
Perceptions of Medical Doctors
Central questions
• What is the position of brands w.r.t. each other?
• Which attributes are related to this positioning?
• Do doctors differ in their perceptions in which brands 
have which attributes? 
HiClas3 Model
Tucker3 hierarchical classes model
Basic elements
• Binary components for all three modes 
(doctors, brands and attributes)
• Plus linkage information about the components
Basic literature
• Papers by Ceulemans, Van Mechelen in Psychometrika
(Catholic University Leuven, Belgium)
1,3,3
HiClas3 – Choosing a Model
Brands × Attributes × Doctors
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Degrees of freedom
1,1,1
2,2,1
3,3,1
2,1,2
1,2,2
2,2,23,2,22,3,2
3,3,2
3,1,3
2,2,3
3,2,3
2,3,3
3,3,3
Model complexity: (3,3,2) = (Brands = 3 components ; Attr = 3; Docs = 2)
Discrepancy : Data have a 1, model matrix a 0 and vice versa
Binary Component Matrices
(brands; attributes)
Brand   Discre-
pancies Fit        B1 B2 B3
------------------------------------
Sulcrate 659    0.626      1  0  1
Cytotec 645    0.564      1  0  0
Zantac    488    0.709      0  0  1
Pepcid 388    0.743      0  0  1
Axid 467    0.691      0  0  1
Losec 499    0.665      0  0  1
Tagamet 627    0.589      0  1  0
------------------------------------
B1 = Cytoprotective agent
B2 = Tagamet (Oldest)
B3 = Histamines; H-2 blocker
Attribute        Discre-
pancies Fit  A1 A2 A3
----------------------------------------
Relieves Pain       369    0.79  1  1  1
Relieves Symptoms 330 0.82  1  1  1
Promotes Health     406    0.77  1  1  1
No Side Effects     517    0.60  0  0  1
Relatively Safe     542    0.57  0  0  1
Flexible Dose       632    0.52  0  1  0
Prophylatic 500    0.61  1  0  0
Low Cost            477    0.00  0  0  0
----------------------------------------
A1 = Primary medical
A2 = Use in practice
A3 = Secondary medical
Low Cost had no 
relations with 
other attributes
Binary Component Matrices
(doctors)
Doctors  MD1 MD2  f  Prop. 1s                     
------------------------------------------
Doctor Type 1 1    1 70     .73
Doctor Type 2 1    0 69     .50
Doctor Type 3 0    1 98     .61
Doctor Type 4 0    0  46 .28
------------------------------------------
Average sd = .09
Doctor Type 4 (0,0) has no links with other doctors
Binary Core Array
Dr2 (1 0) A1 A2    A3
Prim. Prac Secon.
Med.  tice Med.
---------------------------------------
B1 (Cytoprotective)   1      0      0
B2 (Tagamet )   1      1      0
B3 (Histamines    )   1      0      0
---------------------------------------
Dr3 (0 1)
---------------------------------------
B1 (Cytoprotective)   1      0      1
B2 (Tagamet )   0      1      0
B3 (Histamines    )   0      1      1
---------------------------------------
1 : a link exists between components of the three modes
Dr1 = 
Dr2 + Dr3
No side effects
Safe
Doctor Type 2
Sulcrate
Zantac, Axid, Pepcid, Losec Cytotec Tagamet
Relieves pain and symptoms, Promotes health
Low costFlexible doseProphylactic
A
n = 69
Doctor Type 3
Sulcrate
Zantac, Axid, Pepcid, Losec Cytotec Tagamet
Relieves pain and symptoms, Promotes health
Low costFlexible doseProphylacticNo side effects
Safe
n = 98
Doctor Type 1
Sulcrate
Zantac, Axid, Pepcid, Losec Cytotec Tagamet
Relieves pain and symptoms, Promotes health
Low costFlexible doseProphylacticNo side effects
Safe
A
n = 70
Doctor Types
Sulcrate
Zantac, Axid, Pepcid, Losec Cytotec Tagamet
Relieves pain and symptoms, Promotes health
Low cost
Flexible doseProphylacticNo side effects
Safe
A
Dr3
Dr2
Dr1
Characterisation of Doctor Types
a0, a1, a2,XXa0,      ,a2a0, a1, a2Tagamet
a0, a1, a2, a3a0, a1, a2, a3a0, a1Sulcrate
a0, a1, XX,a3a0, a1,      ,a3a0, a1Cytotec
a0, a1, a2, a3a0,      ,a2, a3a0, a1Losec
a0, a1, a2, a3a0,      ,a2, a3a0, a1Pepcid
a0, a1, a2, a3a0,      ,a2, a3a0, a1Axid
a0, a1, a2, a3a0,      ,a2, a3a0, a1Zantac
Dr 1 (n=70)Dr 3 (n=98)Dr 2 (n=69)Brand Name
• a0={Relieves Pain, Relieves Symptoms, Promotes Healing}
• a1={Prophylactic}, a2={Flexible Dosage}, a3={No Side Effects, Safe}
•Doctor Type 4 has no links; Low Cost has no links
Further Considerations
• No information on Low Cost (more complex HiClas 
models can model a separate component for Low Cost)
• Tagamet is relatively inexpensive, while the others are 
not 
• Don’t the doctors see this?
• HiClas3 suggest they do not.
Proportions of Ones across Doctors
Tagamet Zantac PepCid Axid Losec Sulcrate Cytotec
RelievePain .8 .9    .8     .7 .8     .7 .5
RelieveSymptoms .9 .9 .8     .8 .9     .7 .6
PromotesHealth .7 .8    .7     .7 .8     .7 .6
NoSideEffect .3 .7 .6     .6 .4 .8 .4
RelativeSafe .2 .6 .5     .5 .4     .7 .4
FlexbileDose .7 .7 .5     .4   .3     .4       .3
Prophylactic     .4 .5    .4     .3   .2     .6 .7
LowCost .7 .2    .2 .2 .0     .3       .1
Further Considerations
• Surprise
Tagamet is the only relatively inexpensive brand
• Possible reason:
Doctors from all groups say Tagamet is not expensive.
Thus unrelated to the present groups.
• Possible solution:
More groups for attributes 
(we are working on this)
• Question
Other variability not present in HiClas solution?
Further Analyses
• Treat the binary data as numerical and analyse with 
Tucker3.
• Handle the data such that emphasis is on:
– relative differences between brands
– relative differences between attributes.
Three-Mode Component Analysis
•Concentrate on consensus and individual
differences between doctors in the relationships
between brands and attributes.
• Absolute differences between brand and
between attributes are ignored.
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Joint Biplot
(Consensus among doctors - Mean)
First Component
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Tagamet Zantac
Pepcid
Sulcrate
Cytotec
Axid
LosecRelPain
NoSideEff
Safe
FlexDoseLowCost
RelSymptoms
Heals
Prophylactic
Mean of each brand 
and each attribute
Joint Biplot
(Individual differences between doctors - Deviations from mean)
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Conclusions - 1
HiClas model
• Given the data are binary, the binary hierarchical classes 
model is an obvious analysis method and has a relatively 
straightforward interpretation.
• Effective graphics to display results
• Many components might be necessary to model all  
systematic variability present.
Conclusions - 2
Tucker3 model
• By using a numerical model variance can be portrayed in 
a different and also insightful manner 
• Differential weighting may simplify model description
• Enlightning graphics are available (joint biplots), but it 
requires some training to understand them
Conclusions - 3
Substantive conclusions concern the perceptual mappings 
of the brands with respect to the attributes as seen by the 
doctors.
The main patterns have been discussed during the 
presentation and will not be repeated.
Thank You.
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Tucker3 Model in Matrix Notation
A, (I × P) loadings matrix for brands
B, (J × Q) loadings matrix for attributes
C, (K × R) loadings matrix for subjects
G, (P × Q × R) core array with links between the 
components
ε+⊗= )''( CBAGX
PARAFAC/CANDECOMP Model:
• (Harshman 1970, 1976; Harshman and Lundy 1984, 1994; Carroll and Chang 1970)
• Based on the principle of Parallel Proportional Profiles (Cattell 1944).
∑
=
==
S
s
ksjsissssijkijk cbagmx
1
ˆ
mijk is the model matrix or structural image
A is the (I × S) loadings matrix for brands
B is the (J × S) loadings matrix for attributes
C is the (K × S) loadings matrix for subjects
G is the (S × S × S) superdiagonal core array 
exclusive links between the components s of the three modes
MODELS     NUMBER OF COMPONENTS   STANDARDIZED  Number  St.Fit/#Param 
             A     B     C           SS          of       (x1000) 
________   _____ _____ _______   ____________   Param.  ____________ 
 
TUCKALS2     3     3    ---         .49         2754      .19  
 
TUCKALS2     2     3    ---         .40         1723      .23 
 
TUCKALS3     3     3     5          .40         1462      .27  
 
TUCKALS2     2     2    ---         .31         1154      .27 
TUCKALS3     2     2     4          .31         1154      .27 
TUCKALS3     2     3     4          .35         1165      .30 
TUCKALS3     3     3     4          .37         1179      .37  
 
TUCKALS3     3     3     3            
TRILIN       3     3     3          .32          888      .36  
TUCKALS3     2     3     3          .32          883      .36 
 
 
TUCKALS3     2     2     2          .27          592      .46 
TRILIN       2     2     2          .27          592      .46 
TUCKALS3     2     3     2          .28          599      .47  
 
COMPUTATION OF NUMBER OF PARAMETERS: 
 
A  +  B  +  C  + core  - transformational freedom 
-------------------------------------------------------------- 
TUCKALS2:   I*P + J*Q +     + P*Q*K - P**2 - Q**2 
TUCKALS3:   I*P + J*Q + K*R + P*Q*R - P**2 - Q**2 - R**2 
PARAFAC :   I*S + J*S + K*S + S     - S    - S    - S 
Three-Mode Components Analysis: Model 
Comparison
Varimax Rotation: Deciding On Weights 
Relative Weights  Varimax Value 
A B C  Core A B C 
 unrotated  2.136        1.130 1.099 1.503 
0 0 0 2.782        1.600 1.404 1.488 
0.5 0.5 0.5 2.665        2.635 2.336 1.490 
1.0 1.0 1.0 2.603        2.643 2.416 1.491 
1.5 1.5 1.5 2.561        2.644 2.446 1.494 
2.0 2.0 2.0 2.519        2.644 2.463 1.501 
2.5 2.5 2.5 2.443        2.644 2.475 1.523 
3.0 3.0 3.0 2.180        2.635 2.454 1.678 
3.5 3.5 3.5 2.134        2.637 2.465 1.679 
4.0 4.0 4.0 2.099        2.638 2.473 1.679 
4.5 4.5 4.5 2.071        2.640 2.478 1.679 
5.0 5.0 5.0 2.049        2.640 2.482 1.680 
5.5 5.5 5.5 2.030        2.641 2.484 1.680 
100 100 100 1.895        2.644 2.470 1.681 
1000 1000 1000 1.843        2.644 2.498 1.681 
10000 10000 10000 1.842        2.644 2.498 1.681 
0.5 0.5 3.0 2.629        2.641 2.274 1.520 
0.5 1.0 3.0 2.522        2.644 2.424 1.522 
1.0 1.0 3.0 2.522        2.644 2.424 1.522 
1.0 1.0 3.5 2.582        2.596 2.250 1.678 
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  First Component
 Joint biplot for Brands       and Attrubutes  
   First versus   Third Component 
 for  Second Component of Doctors     
16/05/08 10:48:17
 Tagamt
 Zantac
 PepCid
 Sulcrt
 Cytotc
 Axid
 Losec
 RlvPn
 NoSiEf
 RelSaf
 FlxDoz
 NotCst
 RlvSym
 PromHl
 Prophy
Components for Brands and Attributes
Mode
Unrotated Components
(Orthonormal)
Components After
Varimax Rotation of
the Core Matrix
Components After Joint
Varimax Rotation of
Components and the
Core
1 2 3 1 2 3 1 2 3
Brands:
A .595 -.701 .836 -.385 .919 .034
G .098 .213 -.001 .234 -.175 .371
D -.609 -.385 -.390 -.606 -.220 -.414
E -.462 -.083 -.384 -.270 -.074 -.716
B .089 .304 -.048 .031 -.159 .259
C .105 .285 -.025 .302 -.184 .258
F .183 -.367 .011 .410 -.107 .209
Attributes:
Inexp .481 .536 -.012 .573 -.436 -.001 .709 .100 .080
NoSiEf -.350 -.222 .127 -.361 .188 -.149 -.419 -.005 .111
Safe -.467 -.251 .229 -.461 .225 -.266 -.535 -.001 .218
Prophy -.490 .575 -.421 -.424 -.736 .160 -.006 .863 -.064
RelPain .291 -.302 -.122 .194 .301 .249 .050 -.327 -.284
FlexDo .130 .195 .762 .302 .036 -.737 .177 -.261 .732
RelSym .245 -.278 -.267 .130 .234 .371 .037 -.224 -.397
Heals .160 -.253 -.296 .048 .188 .373 -.013 -.145 -.395
Core Array
Unrotated Varimax Rotation of the
Core Only
Joint Varimax
Rotation of the
Components and the
Core
Components for
Brands:
Components for Attributes
Frontal Slice 1:
1 2 3 1 2 3 1 2 3
1 13.777 -2.269 2.164 14.441 .045 .550 14. 105 -1.235 .610
2 -3.628 -10.714 .950 .202 10.959 .562 .592 -9.748 .563
Frontal Slice 2:
1 2 3 1 2 3 1 2 3
1 -2.081 5.647 3.469 -.672 4.805 2.312 -.048 2.372 -.804
2 -5.500 -.754 4.409 4.306 1.911 7.113 -2.241 7.680 7.997
Assessment of Goodness of Model 
Fit:
• Kroonenberg and De Leeuw (1980), and Kroonenberg (1983) show that 
SS(Residual) = SS (Total) - SS(Fit)
SS Accounted For = SS(Fit) / SS (Total)
• Also, as it has been shown by Ten Berge, De Leeuw, and Kroonenberg (1987), 
when the ALS algorithm has converged,
SS (Residualm) = SS (Totalm) - SS(Fitm)
where m stands for any level of any mode of the data matrix.
• Using the last relationship, the relative fit of individual levels of a mode can be 
established. Also, whether a given level fits the model well or badly can be 
determined.
Model selection Tucker3 model
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Sum of Numbers of Components (S = P + Q + R)
 Deviance versus Sum of Numbers of Components 
 (Three-Mode Scree Plot)
16/05/08 09:58:28
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Deviance versus Sum of Numbers of Components
Tucker 3 Solutions 
 
                               Raw SS         Standardized SS 
 SS(Total)                    1564.857             1.0000                                 
 A.EST.SS(Fit)                 885.938              .5661 
 B.EST.SS(Fit)                1008.107              .6442 
 C.EST.SS(Fit)                 465.270              .2973 
 
 SS(Fit)                       430.970              .2754 
 SS(Residual)                 1133.887              .7246 
 
DF = Number of data points (minus loss of information  
due to preprocessing or missing data) minus the number of independent parameters 
 
Number of independent parameters =  
(I*P) + (J*Q) + (K*R) + (P*Q*R) - P**2 - Q**2 - R**2  
 
with I, J, K the numbers of levels of 1st, 2nd, and 3rd modes, respectively,  
 
and P, Q, R the numbers of components of 1st, 2nd, and 3rd modes, respectively. 
 
 
 
Relating Subject Components to 
External Variables
• Y: Number of years of experience as a medical doctor 
(standardized)
• X1 : First component score for “subjects” mode,  
• X2:  Second component score for “subjects” mode,
• Linear Model:  Y = X1 B1 + X2 B2 
• Estimates: B1= -1.054 , std. error = 0.997, t= 1.058, p-value=0.29
• B2 = 1.350,  std. error = 0.997, t =1.345, p-value=0.18
• R2=0.01, F-value=1.477, df=(2, 282), p-value=0.23.
• Conclusion: Subject components are not related to number of years 
of experience as a medical doctor. 
Relating Residuals to External 
Variables:
• Y: Number of years of experience as a medical doctor 
(standardized)
• X: Sum of squares of residuals for each subject
• Linear Regression:  Y = B X 
• Estimated B = - 0.006,  R2= 0.0007, F-value = 0.212, d.f. = (1, 282)
• p-value = 0.646
• Conclusion : Residuals are not related to number of years of 
experience. 
Result HiClas3-model (2D×3A×3B)
Sulcrate
Zantac, Axid, Pepcid, Losec Cytotec Tagamet
Relieves pain and symptoms, Promotes health
Low costFlexible doseProphylacticNo side effects
Safe
D4D1,D3 D1,D3 D1,D3 D1,D2 D1,D2
D1 (1 1) = 70
D2 (1 0) = 69
D3 (0 1) = 98
D4 (0 0) = 46
HICLAS3: Example 
(Tucker3-HICLAS)
Accused by instructor; 
People tell lies about you;  
Persistently contradicted;    
Unfairly blamed for error
 Ignored in restaurant;   
Disconnecting operator; 
Closing store; 
Missing page in book;
 
Grimace
Turn away; Lose patience; 
Feel irritated; Curse
Become enraged; 
Become tense; 
Heart beats faster
P1
 P3
P1
P3
P2
P3
   
Hands tremble; 
Perspire; Want to strike
   
Stimuli
Subjects
Response
Based on example Leuven group
(11)
(10)
(010)
(100)
(011)(111)
HiClas3 – Three-mode scree plot
Doctors × Attributes × Brands
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Sum of Numbers of Components (S = P + Q + R)
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Preprocessing: Double Centring
(in three-mode component analysis)
• Double centring: 
doctors may not use the 
attrubutes uniformly across 
the brands and across the 
attributes.
• Double centring:
Scores in deviations from 
brand means
attribute means. 
Origin = zero point for both 
brands and attributes of each 
subject’s scores
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Preprocessing: Double centring
ijkijjkikkjiijk abcabbcaccbamx +++++++=
Three-way factorial design without replacement (1 observation per cell):
Dependent variable: Brand possesses attribute (score = 1)
After centring:
Analysed with Three-mode PCA
abij = consensus of doctors about attributes of brands
abcijk = differences between doctors about attributes of brands
Model selection Tucker3 model
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Degrees-of-Freedom
Deviance versus Degrees-of-Freedom
1x1x1
2x2x1
3x3x1
2x1x2
1x2x2
2x2x2
3x2x2
2x3x2
3x3x2
3x1x3
2x2x3
3x2x3
1x3x3
2x3x3
3x3x3
Model complexity: (Docs = 2; Attr = 3; Brands = 3) or (Docs = 3; Attr = 3; Brands = 3)
Joint biplot
(Consensus)
First Component
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Conclusions
Where to go from here
• Irregular patterns in some doctors combined with low number of ones 
were excluded from the HiClas analysis while these doctors were 
scattered all over the plot of the doctors’ components.
Thus Tucker analysis picked up some information which was not 
available to the HiClas analysis. Similarly for the LowCost attribute.
• Is the numerical information such as the variance somewhere to be 
found in the HiClas results and if so can it be used?
• Construct exactly fitting hierarchical classes models and run a Tucker3 
analysis on them.
• Construct doctors/attributes/brands artificially according to a specific 
pattern and include them in the analysis to facilitate interpretation.
• Sort out the mathematics of the comparison between models.
HiClas3 – Three-Mode Deviance Plot
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